Back to Medicine Index

Dapaglip 5 mg

Tablet

Generic: Dapagliflozin

Incepta Pharmaceuticals Ltd.

Therapeutic Class: SGLT2 Inhibitor (Oral Antidiabetic)

Indications

Type 2 diabetes mellitus in adults, as an adjunct to diet and exercise. Symptomatic chronic heart failure. Chronic kidney disease.

Pharmacology

Dapagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidney, reducing reabsorption of filtered glucose and increasing its excretion in the urine. It lowers blood glucose independently of insulin.

Dosage & Administration

Adult: 10 mg once daily, at any time of day, with or without food. A starting dose of 5 mg once daily may be used where advised by the physician, for example in severe hepatic impairment.

Side Effects

Genital fungal infection, urinary tract infection, increased urination, thirst, dizziness and back pain. Diabetic ketoacidosis and severe infection of the genital area are rare but serious.

Precautions & Warnings

Assess kidney function before and during treatment. Maintain fluid intake and good genital hygiene. Stop temporarily during acute illness, dehydration or before major surgery. Seek help at once for nausea, vomiting, abdominal pain or rapid breathing. Avoid in pregnancy and breast-feeding.

Contraindications

Hypersensitivity to dapagliflozin, type 1 diabetes, diabetic ketoacidosis and patients on dialysis.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.